Printer Friendly

Browse Bacterial pneumonia topic

Drug therapy subtopic


1-155 out of 155 article(s)
Title Author Type Date Words
Allergan receives US FDA approval for supplemental new drug application to expand approved use of Avycaz. Feb 5, 2018 190
Allergan receives US FDA approval for supplemental new drug application to expand approved use of Avycaz. Feb 5, 2018 194
Allergan plc wins US FDA's approval for supplemental sNDA for the expanded use of AVYCAZ for HABP &VABP. Feb 2, 2018 308
Allergan plc wins US FDA's approval for supplemental sNDA for the expanded use of AVYCAZ for HABP &VABP. Feb 2, 2018 304
Pneumonia Drug Development Pipeline Review, 2017. Oct 12, 2017 579
FDA Accepts Supplemental New Drug Application (sNDA) filing for AVYCAZ (ceftazidime and avibactam). Oct 2, 2017 2125
When to "CAP" off treatment for pneumonia: Is 5 days of antibiotic therapy really sufficient for adults hospitalized with community-acquired pneumonia? Castelli, Gregory; Jarrett, Jennie B.; Lyon, Corey Case study Oct 1, 2017 1441
NIAID, Zavante Partner in Clinical Trial of Zolyd as Bacterial Pneumonia Treatment. Sep 11, 2017 400
Aridis Pharmaceuticals Begins Patient Enrollment in International Study of Aerucin for Treatment of Acute Pneumonia. Aug 3, 2017 236
Mcr-1 and [bla.sub.KPC_3] in Escherichia coli sequence Type 744 after meropenem and colistin therapy, Portugal. Tacao, Marta; Tavares, Rafael dos Santos; Teixeira, Pedro; Roxo, Ines; Ramalheira, Elmano; Ferreira, Report Aug 1, 2017 1953
Amyopathic Dermatomyositis Associated with Histopathological Findings of Organizing Pneumonia and Pulmonary Vasculitis. Lim, Jeong Uk; Kang, Hye Seon; Kim, Yong Hyun; Kim, Tae-Jung Case study Aug 1, 2017 1685
Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial. Liu, Chang; Zhang, Yu-Ting; Peng, Zhi-Yong; Zhou, Qing; Hu, Bo; Zhou, Hui; Li, Jian-Guo Report Jul 27, 2017 4262
Community-acquired bacterial pneumonia: is there anything new? Liu, Hans Apr 1, 2017 4899
Acid blockers boost infections in preemies' first year. Zoler, Mitchel L. Jun 1, 2016 696
Infective endocarditis caused by Klebsiella oxytoca in an intravenous drug user with cancer. Mohamed, Ashref; Hall, Connor; Hatch, Michael; Ayan, Mohamed; Winn, Richard Clinical report Apr 1, 2016 1440
Linezolid-induced serotonin toxicity in a patient not taking monoamine oxidase inhibitors or serotonin receptor antagonists. Sutton, Jacob; Stroup, Jeff; Som, Mo Clinical report Apr 1, 2016 1133
A Pilot Study of Quantitative Loop-mediated Isothermal Amplification-guided Target Therapies for Hospital-acquired Pneumonia. Wang, Fang; Li, Ran; Shang, Ying; Wang, Can; Wang, Guo-Qing; Zhou, De-Xun; Yang, Dong-Hong; Xi, Wen; Report Feb 1, 2016 3372
Oral solithromycin shown effective in severe CAP. Zoler, Mitchel L. Nov 15, 2015 701
Comparison of the efficacy of colistin monotherapy and colistin combination therapies in the treatment of nosocomial pneumonia and ventilator-associated pneumonia caused by Acinetobacter baumannii. Kara, I.; Yildirim, F.; Bilaloglu, B.; Karamanlioglu, D.; Kayacan, E.; Dizbay, M.; Turkoglu, M.; Ayg Report Nov 1, 2015 6787
This adjunct medication can speed CAP recovery: adding prednisone to the antibiotic regimen can help patients hospitalized with community-acquired pneumonia to stabilize more quickly and leave the hospital sooner. Kirley, Katherine; Jarrett, Jennie Broders; Sauereisen, Sandra Clinical report Oct 1, 2015 1514
Allergan Announces FDA Approval of Updated Label for TEFLARO (ceftaroline fosamil). Sep 2, 2015 2346
A Pharmacokinetic and Pharmacodynamic Study on Intravenous Cefazedone Sodium in Patients with Community-acquired Pneumonia. Gao, Lei; Zhu, Yan; Lyu, Yuan; Hao, Feng-Lan; Zhang, Pu; Wei, Min-Ji Report Sep 1, 2015 2566
Nocardial pneumonia in an immunocompetent young female: a rare entity. Srivastava, Govind Narayan; Meena, Manoj; Dixit, Ramakant; Kewlani, Jai Prakash; Harish, Sabarigiri Case study Aug 1, 2015 1342
Beta-lactam monotherapy effective for suspected CAP. Moon, Mary Ann Apr 15, 2015 404
A meta-analysis of efficacy and safety of doripenem for treating bacterial infections. Qu, Xiao-Yu; Hu, Ting-Ting; Zhou, Wei Report Mar 1, 2015 3936
End-of-Project Evaluation of UNICEF s Diarrhoea and Pneumonia Treatment Initiative". Feb 10, 2015 126
Nabriva Therapeutics Announces Qualified Infectious Disease Product and Fast Track Status Granted by the US FDA for Lefamulin. Oct 8, 2014 904
Nabriva Therapeutics Announces Qualified Infectious Disease Product and Fast Track Status Granted by the US FDA for Lefamulin. Oct 8, 2014 908
The global challenge of bacterial pneumonia: can molecular testing improve patient care? Thews, Anne Report Sep 1, 2014 2172
'Body clock' makes drugs for treating pneumonia ineffective. Jul 28, 2014 258
TaiGen Biotechnology Receives Marketing Approval from the Taiwan Food and Drug Administration for Taigexyn(R) (nemonoxacin) in Taiwan. Mar 13, 2014 700
Determinants, outcomes and costs of ceftriaxone v. amoxicillin-clavulanate in the treatment of community-acquired pneumonia at Witbank hospital. Xaba, S.N.; Greeff, O.; Becker, P. Report Mar 1, 2014 4200
Can prophylactic antibiotics for aspiration improve stroke outcomes? The PANTHERIS trial. Jan 31, 2014 663
Community-acquired pneumonia at the Hospital de Clinicas de Porto Alegre: evaluation of a care protocol. Mocelina, Clei Angelo; dos Santos, Rodrigo Pires Report Sep 1, 2013 3364
Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011. Hong, Ki Bae; Choi, Eun Hwa; Lee, Hoan Jong; Lee, Seong Yeon; Cho, Eun Young; Choi, Jae Hong; Kang, Aug 1, 2013 2584
Unique clone of Coxiella burnetii causing severe Q fever, French Guiana. Mahamat, Aba; Edouard, Sophie; Demar, Magalie; Abboud, Philippe; Patrice, Jean-Yves; La Scola, Berna Jul 1, 2013 1825
Etiological profile in patients with ventilator associated pneumonia in ICU at a tertiary care hospital. Mudda, Anil; Sanjeev, Kumar S.G.; Kumar, Ravi; Shruthi, Sai; Kumar, T. Anil Clinical report Apr 15, 2013 2092
Nelson Mandela discharged from hospital following successful pneumonia treatment. Apr 7, 2013 195
Nelson Mandela 'Responding Well' to Hospital Treatment for Pneumonia. Mar 30, 2013 341
Pfizer Receives FDA Approval For The Use Of Prevnar 13 In Vaccine-Naive Children And Adolescents Aged 6 Years Through 17 Years For The Prevention Of Invasive Pneumococcal Disease. Jan 25, 2013 1457
Durata Therapeutics Announces Preclinical Data Supporting Clinical Development of Dalbavancin for the Treatment of Pneumonia. Clinical report Oct 18, 2012 774
A survey on pulmonary pathogens and their antibiotic susceptibility among cystic fibrosis patients. Kharibabaee, Ghamartaj; Akbarizadeh, Majidreza; Sayyari, Aliakbar; Ashayeri-Panah, Mitra; Abdollahgo Mar 1, 2012 3010
Pneumonia vaccine approved for age 50 and up. Mechcatie, Elizabeth Jan 1, 2012 566
Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients. Chung, J.; Oh, J.M.; Cho, E.M.; Jang, H.J.; Hong, S.B.; Lim, C.M.; Koh, Y.S. Clinical report Nov 1, 2011 5059
Cempra Announces Comparable Efficacy of Oral Solithromycin (CEM-101) Compared with Levofloxacin in Phase II Clinical Trial in Patients with Community-Acquired Bacterial Pneumonia (CABP). Sep 15, 2011 882
Drug resistant Pneumonia is leading to increasing incidence of difficult to treat cases. Aug 8, 2011 653
Furiex Pharmaceuticals' Antibiotic Program Featured in Two Abstracts at 21st ECCMID/27th ICC Joint Congress. May 5, 2011 841
Recent onset of confusion, limited mobility, and disturbed sleep-wake cycle: this elderly woman had received treatment the week before for pneumonia and paranoid behavior, how would you proceed with her care? Rehman, Habib U.; Prasad, B. Interview May 1, 2011 1592
Multiple errors end in death from pneumonia. Susman, Jeffrey L. Brief article May 1, 2011 232
Nabriva Reports Positive Results from Phase II Trial of Pleuromutilin Antibiotic BC-3781 in ABSSSI. Clinical report Apr 18, 2011 920
Acute cytomegalovirus pneumonitis in patient with lymphomatoid granulomatosis. Wu, Shang-Gin; Tsai, Tzu-Hsiu; Wu, Shang-Ju Letter to the editor Apr 1, 2011 1171
Cytomegalovirus viremia, pneumonitis, and tocilizumab therapy. van Duin, David; Miranda, Cyndee; Husni, Elaine Case study Apr 1, 2011 1350
Isoniazid (INH)-lnduced eosinophilic exudative pleural effusion and lupus erythematosus: a clinical reminder of drug side effects. Khattri, Saakshi; Kushawaha, Anurag; Dahal, Kumud; Lee, Maryann; Mobarakai, Neville Apr 1, 2011 2738
Best of ... more about: duration of antimicrobial therapy. Senekal, Marthinus Jan 1, 2011 447
Acid-suppressive drugs increase chances of hospital-acquired pneumonia. Dec 22, 2010 141
Acid suppressive drugs may increase pneumonia risk. Dec 21, 2010 159
Activity Against Key Drug-Resistant Pathogens is the Most Important Attribute Influencing Surveyed Physicians' Antibiotic Selection for Nosocomial Pneumonia in the U.S. Nov 2, 2010 498
Protect yourself from the flu and pneumonia by getting vaccinated. Nov 1, 2010 799
Forest Announces FDA Approval of Teflaro[TM] (ceftaroline fosamil) for the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection. Oct 29, 2010 2157
Antipsychotic drugs can cause pneumonia in the elderly. Sep 22, 2010 212
Community-based treatment of malaria, pneumonia could save lives: Study. Sep 22, 2010 508
Nosocomial C. difficile common in pneumonia. Jancin, Bruce Report Sep 1, 2010 543
Old Drug Holds Promise Against Opportunistic Lung Bug. Aug 19, 2010 1338
Advanced Life Sciences Applies for FDA Fast-Track Designation for Restanza in CABP. Jul 28, 2010 918
Bacterial meningitis in the era of paediatric vaccination against the encapsulated pathogens: bacterial meningitis is still prevalent worldwide in spite of effective vaccines. Gottberg, Anne Von Jun 1, 2010 4071
More about ... bacterial diseases duration of antimicrobial therapy. Senekal, Marthinus Jun 1, 2010 671
Stubborn pneumonia turns out to be cancer. Susman, Jeffrey L. Brief article Apr 1, 2010 163
Pneumonia linked to anti-inflammatory drug. Mar 22, 2010 211
Vibativ's Delayed Approval for Nosocomial Pneumonia Will Significantly Reduce Its Commercial Impact in the Methicillin-Resistant Staphylococcus Aureus Drug Market. Feb 18, 2010 821
Brittany Murphy died from pneumonia, anemia, drugs. Feb 6, 2010 239
Brittany Murphy died from pneumonia, anemia, drugs. Feb 5, 2010 239
Proton pump inhibitor suppression of calcium absorption presenting as respiratory distress in a patient with bilateral laryngeal paralysis and hypocalcemia. Zaya, Ninef E.; Woodson, Gayle Clinical report Feb 1, 2010 1687
Theravance gives update on telavancin NDA for treatment of nosocomial pneumonia. Jan 29, 2010 155
Novel treatment approach to combat an infection with Acinetobacter. Stroup, Jeffrey S.; Mitchell, Kendal; Hitzeman, David Report Jan 1, 2010 1584
Optimal therapy for multidrug-resistant acinetobacter baumannii. Cunha, Burke A. Report Jan 1, 2010 1029
A refractory case of community--acquired pneumonia: three days after beginning a course of steroids and IV antibiotics, the patient still needed oxygen and her white blood cell count was climbing. Schlaudecker, Jeffrey D. Case study Nov 1, 2009 1526
In vitro synergistic effect of doxycycline & ofloxacin in combination with ethanolic leaf extract of Vangueria spinosa against four pathogenic bacteria. Chatterjee, Soroj Kumar; Bhattacharjee, Indranil; Chandra, Goutam Report Oct 1, 2009 2694
Forest Laboratories Presents Analysis of Two Positive Pivotal Phase III Studies of Ceftaroline for the Treatment of Community-Acquired Pneumonia (CAP) at ICAAC. Sep 12, 2009 1812
Increase in pneumococcus macrolide resistance, United States. Jenkins, Stephen G.; Farrell, David J. Report Aug 1, 2009 3947
Long-term use of inhaled corticosteroids increases the risk of pneumonia. Apr 1, 2009 141
Emerging community-acquired methicillin-resistant staphylococcus aureus pneumonia. Orlovic, Dragana; Smego, Raymond A. Report Apr 1, 2009 2920
Inhaled corticosteroids 'up pneumonia risk by one third in lung disease sufferers'. Dec 3, 2008 501
Study of dihydropteroate synthase (DHPS) gene mutations among isolates of Pneumocystis jiroveci. Tyagi, A.K.; Mirdha, B.R.; Guleria, Randeep; Mohan, Anant; Luthra, Kalpana; Singh, U.B. Report Dec 1, 2008 3163
Standard of care. Tan, S.Y. Oct 15, 2008 880
Medication reconciliation matters. Young, Beth Case study Oct 1, 2008 3553
TYGACIL approved for treatment of patients with CAP. Jul 1, 2008 178
Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry. Curcio, Daniel; Fernandez, Francisco; Cane, Alejandro; Barcelona, Laura; Stamboulian, Daniel Report Jun 1, 2008 3108
Intravenous azithromycin plus ceftriaxone followed by oral azithromycin for the treatment of inpatients with community-acquired pneumonia: an open-label, non-comparative multicenter trial. Rubio, Fernando G.; Cunha, Clovis A.; Lundgren, Fernando L.C.; Lima, Maria P.J.S.; Teixeira, Paulo J Report Jun 1, 2008 6166
Ventilator-associated pneumonia in an adult clinical-surgical intensive care unit of a Brazilian university hospital: incidence, risk factors, etiology, and antibiotic resistance. da Rocha, Laura de Andrade; Vilela, Carolina Assis Pereira; Cezario, Renata Cristina; Almeida, Alair Report Feb 1, 2008 4592
Pneumonia patients admitted late to ICU have higher mortality. Finn, Robert Brief article Jan 1, 2008 225
Pneumonia: 3 to 5 days of antibiotics is as effective as 10 days. Dec 1, 2007 317
Editor's choice. Dec 1, 2007 888
Management of community-acquired pneumonia in adults. Feldman, C.; Brink, A.J.; Richards, G.A.; Maartens, G.; Bateman, E.D. Clinical report Dec 1, 2007 5741
Levofloxacin safe, effective against pneumonia in children. Sullivan, Michele G. Nov 1, 2007 568
Poor adherence to South African guidelines for the management of community-acquired pneumonia. Nyamande, K.; Lalloo, U.G. Clinical report Aug 1, 2007 2227
July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of FACTIVE(R) Tablets for Five-Day Treatment of Community-Acquired Pneumonia. Jun 12, 2007 1392
Can history and exam alone reliably predict pneumonia? Trust your judgment (and your radiologist) when deciding whether to give antibiotics. Graffelman, A.W.; le Cessie, S.; Neven, A. Knuistingh; Willemssen, F.E.J.A.; Zonderland, H.M.; van d Clinical report Jun 1, 2007 3568
Marker may help tailor antibiotic use in CAP. Johnson, Kate Jun 1, 2007 642
COPD, comorbid pneumonia present diagnostic and treatment challenges. Johnson, Kate Jun 1, 2007 206
Biologic marker can help tailor antibiotic use in CAP. Jun 1, 2007 634
Appropriate antibiotic important in COPD with pneumonia. Jun 1, 2007 314
Are wide-spectrum antibiotics overused in mild pneumonia? Johnson, Kate May 15, 2007 651
Antibiotic use for mild CAP debated across pond. Johnson, Kate May 15, 2007 598
FDA Approves Oscient Pharmaceuticals' FACTIVE(R) Tablets for Five-Day Treatment of Community-Acquired Pneumonia. May 2, 2007 1351
New Treatment Guidelines for Community-Acquired Pneumonia Highlight Utility of FACTIVE Tablets. Feb 22, 2007 1238
Four-hour antibiotic rule for CAP may hamper care. MaHoney, Diana Clinical report Feb 1, 2007 329
Macrolide resistance is common cause of breakthrough bacteremia. Boschert, Sherry Jan 15, 2007 407
FDA panel recommends that Sanofi-Aventis antibiotic Ketek should not be marketed for sinusitis or bronchitis. Brief article Jan 1, 2007 249
hMPV tied to alveolar pneumonia. Brunk, Doug Dec 1, 2006 392
New fluoroquinolone for community-acquired pneumonia is promising. Boschert, Sherry Clinical report Dec 1, 2006 385
Noncompliance with antibiotic guideline for CAP may up costs. Jancin, Bruce Clinical report Dec 1, 2006 584
Tigecycline on horizon for community-acquired pneumonia. Boschert, Sherry Dec 1, 2006 508
Identify risk factors to guide pneumonia therapy. Schneider, Mary Ellen Oct 15, 2006 644
Risk factors should guide pneumonia therapy: recommendations focus on using clinical judgment and giving antibiotics before culture results are back. Schneider, Mary Ellen Oct 15, 2006 647
Empiric antibiotic choice overshadows blood cultures in averting pneumonia deaths. Kirn, Timothy F. Oct 15, 2006 347
Steroids gain traction for severe pneumonia. Jancin, Bruce Clinical report Aug 15, 2006 547
Steroids gain traction for severe pneumonia. Jancin, Bruce Clinical report Aug 1, 2006 588
Improve antibiotic compliance with short course. Wendling, Patrice Disease/Disorder overview Jun 15, 2006 450
Pneumonia may be tamed effectively by short-course antibiotics. Jun 1, 2006 427
Tigecycline matches levofloxacin vs. pneumonia. Wendling, Patrice Clinical report Jun 1, 2006 556
Older adult pneumonia burden. Jan 15, 2006 206
Gemifloxacin for inpatient CAP found cost effective. Mahoney, Diana Dec 15, 2005 432
Alter pneumonia prescribing to fight resistance: patients not likely to have resistance should receive focused therapy with macrolides or ketolides. Mahoney, Diana Dec 1, 2005 598
Oscient Pharmaceuticals Submits sNDA to FDA for Five-Day Treatment of New Indications for FACTIVE(R) Tablets. Nov 21, 2005 1350
Use fluoroquinolones selectively in pneumonia: incorrect dosing and duration patterns could lead to the development of resistance to the drugs. Mahoney, Diana Nov 1, 2005 678
Aspiration pneumonia Rx. Worcester, Sharon Brief Article Jun 1, 2005 168
Antibiotic choice makes little difference in CAP. Mills, G.D.; Oehley, M.R.; Arrol, B. Jun 1, 2005 520
Outpatient treatment as effective as inpatient for many with pneumonia. Carratala, J.; Fernandez-Sabe, N.; Ortega, L. May 1, 2005 451
Does quinupristin/dalfopristin (Synercid[R]) treat nosocomial pneumonia comparably to vancomycin? Patrick, Herbert Mar 22, 2005 1392
Findings predict pneumonia treatment failure. Zoler, Mitchel L. Mar 15, 2005 779
Quinolones found comparable in elderly patients with CAP. Brunk, Doug Feb 15, 2005 441
Are fluoroquinolones being overprescribed for CAP? Franklin, Deeanna Feb 1, 2005 590
Prednisone has pneumonia risk for RA patients. Kirn, Timothy F. Jan 15, 2005 443
Antibiotic for 3 days can cure most pneumonia: if a similar strategy were employed in routine practice, it could lead to a drop in antibiotic use. Zoler, Mitchel L. Jan 15, 2005 574
Five clinical factors predict pneumonia treatment failure. Zoler, Mitchel L. Jan 15, 2005 801
Are fluoroquinolones overprescribed for CAP? Franklin, Deeanna Jan 1, 2005 471
Short antibiotic course works for most mild to moderate pneumonia. Zoler, Mitchel L. Jan 1, 2005 493
Quinolones compare in elderly with pneumonia. Brunk, Doug Jan 1, 2005 391
Macrolides on the rise. Splete, Heidi Brief Article Dec 1, 2004 171
Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia. Meshnick, Steven R. Oct 1, 2004 4399
Rx for resistant pneumonia. Brief Article May 1, 2004 168
S. pneumoniae resistance levels off, but too high: latest trends. Jancin, Bruce Nov 1, 2003 526
High-dose, short-term therapy tackles CAP: 'a seminal study'. (community-acquired pneumonia). Jancin, Bruce Nov 1, 2003 693
Azithromycin for CAP. Worcester, Sharon Brief Article Sep 1, 2003 174
CAP: antibiotics and outcomes. Worcester, Sharon Brief Article Jul 15, 2003 147
Radiation pneumonitis successfully treated with inhaled corticosteroids. (Case Report). Crowell, Richard E. May 1, 2003 2020
Antimicrobial drug prescriptions in ambulatory care settings, United States, 1992-2000. (Research). Hughes, James M. Apr 1, 2003 4347
For ventilator-linked pneumonia, linezolid wins: compared with vancomycin. (Infectious Diseases). Walsh, Nancy Apr 1, 2003 309
Switching to oral therapy for pneumonia. (Bottom Line). Boschert, Sherry Apr 1, 2003 413
Community-acquired pneumonia: the best drug. (Fluoroquinolones). Kirn, Timothy F. Mar 1, 2003 388
Fluoroquinolones appear superior for community-acquired pneumonia. (Metaanalysis). Kirn, Timothy F. Brief Article Mar 1, 2003 275
FDA panel supports approval of telithromycin. (Macrolide-Derived Antibiotic). Kubetin, Sally Koch Feb 15, 2003 547
Switching to oral therapy for pneumonia. (Bottomline). Boschert, Sherry Dec 1, 2002 443
Community-acquired pneumonia: help's coming. (New Antibiotics). Boschert, Sherry Dec 1, 2002 535

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters